ALAB vs MKSI

ALAB demonstrates strong financial health with a Piotroski F-Score of 7/9, indicating robust operational efficiency and profitability. The company exhibits exceptional growth momentum with 91.8% YoY revenue growth and 83.6% earnings growth, supported by high margins (75.69% gross, 25.70% net) and a pristine balance sheet with negligible debt (Debt/Equity: 0.02). Despite a high valuation (P/E: 98.61), the intrinsic value estimate of $35.99 and Graham Number of $14.83 suggest significant upside potential if growth is sustained. However, recent insider selling and a bearish technical trend introduce near-term caution. Price trades at a 234.3% premium to fair value estimate ($35.99), limiting near-term upside from a valuation perspective.

MKSI exhibits a stable financial health profile with a Piotroski F-Score of 4/9, though it is currently trading at a massive premium to its Graham Number ($63.07) and Intrinsic Value ($128.91). While the company boasts an exceptional 25-quarter earnings beat streak and strong growth metrics, the valuation is stretched with a trailing P/E of 62.51. This fundamental strength is countered by bearish insider sentiment and a severely weak technical trend (10/100), suggesting the stock may be overextended despite analyst 'buy' ratings.